BRKR

#1174
Bruker Corporation
40.27 USD
+3.12%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
40.11
40.36
Jahresspanne
28.53
56.22
Tagesänderung
+3.12%
Monatliche Änderung
+18.44%
6 month change
+9.85%
Jahresänderung
+0.10%
Vorheriger Schlusskurs
39.05
Eröffnung
40.25
Bid
Ask
Tief
40.11
High
40.36
Volumen
352
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 6.13 B
  • Employee 11 K
  • Founded N/A
  • CEO Frank Laukien
  • Website www.bruker.com
  • Headquarter Delaware, United States
  • FIGI BBG000CL1FG7
  • Industry Technology
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
-314.07
Preis-Umsatz-Verhältnis
2.08
Dividende je Aktie
—
Dividendenrendite in %
—

Bruker Corporation

Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis. It is headquartered in Billerica, Massachusetts, and is the publicly traded parent company of Bruker Scientific Instruments and Bruker Energy & Supercon Technologies divisions. In April 2010, Bruker created a Chemical Analysis Division under the Bruker Daltonics subsidiary. This division contains three former Varian product lines: ICPMS systems, laboratory gas chromatography, and GC-triple quadrupole mass spectrometer. In 2012, it sponsored the Fritz Feigl Prize, and since 1999 the company has also sponsored the Günther Laukien Prize.

Nachrichten